Alexion Pharmaceuticals (ALXN)

Add to Watchlists Create an Alert
99.96 -0.61  -0.61%   NASDAQ May 23, 4:59PM BATS Real time Currency in USD

Alexion Pharmaceuticals Cash from Financing TTM:

297.45M for March 31, 2013
View Full Chart

Alexion Pharmaceuticals Cash from Financing TTM Chart

    Alexion Pharmaceuticals Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 297.45M
    Dec. 31, 2012 666.38M
    Sept. 30, 2012 691.74M
    June 30, 2012 736.83M
    March 31, 2012 333.78M
    Dec. 31, 2011 39.05M
    Sept. 30, 2011 42.05M
    June 30, 2011 42.44M
    March 31, 2011 98.02M
    Dec. 31, 2010 38.87M
    Sept. 30, 2010 10.44M
    June 30, 2010 -10.72M
    March 31, 2010 -7.662M
    Dec. 31, 2009 -14.27M
    Sept. 30, 2009 -0.884M
    June 30, 2009 20.31M
    March 31, 2009 10.01M
    Dec. 31, 2008 28.31M
    Sept. 30, 2008 42.74M
    June 30, 2008 62.28M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Oct. 31, 2005 Go Pro
    July 31, 2005 Go Pro
    April 30, 2005 Go Pro
    Jan. 31, 2005 Go Pro
    Oct. 31, 2004 Go Pro
    July 31, 2004 Go Pro
    April 30, 2004 Go Pro
    Jan. 31, 2004 Go Pro
    Oct. 31, 2003 Go Pro
    July 31, 2003 Go Pro
    April 30, 2003 Go Pro
    Jan. 31, 2003 Go Pro
    Oct. 31, 2002 Go Pro
    July 31, 2002 Go Pro
    April 30, 2002 Go Pro
    Jan. 31, 2002 Go Pro
    Oct. 31, 2001 Go Pro
    July 31, 2001 Go Pro
    April 30, 2001 Go Pro
    Jan. 31, 2001 Go Pro
    Oct. 31, 2000 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    ALXN Cash from Financing TTM Benchmarks

    Companies
    Vertex Pharmaceuticals 144.54M
    Regeneron Pharmaceuticals -68.37M
    Athersys 30.52M

    ALXN Cash from Financing TTM Rankings

    Overall 94th percentile
    421 of 8006
    Sector 96th percentile
    25 of 686 in Healthcare
    Industry 97th percentile
    7 of 248 in Biotechnology

    ALXN Cash from Financing TTM Range, Past 5 Years

    Minimum -14.27M Dec 2009
    Maximum 736.83M Jun 2012
    Average 156.36M